Two new studies have delivered a multitude of new markers linked to testicular cancer, as well as a better understanding of the genetic architecture of the disease.
Exome sequencing data for hundreds of testicular germ cell tumor patients led to the discovery of rare mutations affecting cilia-microtubule genes.
Exome and transcriptome sequences uncovered features that characterized testicular germ cell tumors by whether they did or did not respond to treatment.
Combining the new risk variants with those found in the past, researchers came up with a risk score that may eventually help find those most susceptible to the disease.
NEW YORK (GenomeWeb News) – Two studies appearing in Nature Genetics this week have uncovered about a dozen new loci linked to testicular cancer risk.
NEW YORK (GenomeWeb News) – A subset of non-inherited, early-onset testicular cancer cases involve rare, germline copy number alterations, according to a study appearing online today in the American Journal of Human Genetics.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.